Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 4.0 | 2.0 |
Min SIP Amount | ₹100 | ₹1000 |
Expense Ratio | 1.7 | 1.77 |
NAV | ₹18.81 | ₹36.48 |
Fund Started | 28 Jun 2021 | 11 Feb 2015 |
Fund Size | ₹16856.97 Cr | ₹6354.33 Cr |
Exit Load | Exit load of 1% if redeemed within 12 months. | Exit load of 0.5%, if redeemed within 90 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 29.18% | 22.49% |
3 Year | 20.44% | 10.23% |
5 Year | - | 22.05% |
1 Year
3 Year
5 Year
Equity | 98.61% | 98.59% |
Cash | 1.25% | -0.37% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
TVS Motor Company Ltd. | 9.39% |
ICICI Bank Ltd. | 7.65% |
Maruti Suzuki India Ltd. | 7.58% |
HDFC Bank Ltd. | 4.99% |
Avenue Supermarts Ltd. | 4.62% |
Zomato Ltd. | 3.95% |
Infosys Ltd. | 3.70% |
Redtape Ltd. | 3.52% |
Ethos Ltd. | 3.05% |
Larsen & Toubro Ltd. | 2.89% |
Name | Assets |
---|---|
HDFC Bank Ltd. | 7.61% |
ICICI Bank Ltd. | 7.42% |
Tata Consultancy Services Ltd. | 3.99% |
Reliance Industries Ltd. | 3.81% |
Varun Beverages Ltd. | 3.32% |
Persistent Systems Ltd. | 2.98% |
Bharti Airtel Ltd. | 2.67% |
Dixon Technologies (India) Ltd. | 2.59% |
Multi Commodity Exchange Of India Ltd. | 2.45% |
Sun Pharmaceutical Industries Ltd. | 2.29% |
Name | Rajat Chandak | Vivek Sharma |
Start Date | 28 Jun 2021 | 15 Apr 2024 |
Name
Start Date
Description | The scheme seeks to generate long-term capital appreciation by investing predominately in equity & equity related instruments across market capitalization. | The scheme seeks to generate income & capital appreciation by predominantly investing in an actively managed diversified portfolio of equity & equity related instruments including derivatives. |
Launch Date | 28 Jun 2021 | 11 Feb 2015 |
Description
Launch Date